HM, C., DJ, B., P, D., G, H., A, N., S, L., . . . Charlton-Menys, V. (2011). Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: An analysis from the CARDS trial. Diabetes, 60(9), 2379. https://doi.org/10.2337/db11-0291
Chicago Style (17th ed.) CitationHM, Colhoun, et al. "Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients with Type 2 Diabetes: An Analysis from the CARDS Trial." Diabetes 60, no. 9 (2011): 2379. https://doi.org/10.2337/db11-0291.
MLA (9th ed.) CitationHM, Colhoun, et al. "Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients with Type 2 Diabetes: An Analysis from the CARDS Trial." Diabetes, vol. 60, no. 9, 2011, p. 2379, https://doi.org/10.2337/db11-0291.